Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB017 (PEGylated Interferon Beta-1a) in Healthy Volunteers
NCT02125578Phase 1Completed
- Sponsor
- Biogen
- Start
- Mar 2008
- Primary completion
- May 2008
- Modality
- Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of interferon beta in multiple sclerosis (MS) (3 arms), sponsored by Biogen. Primary endpoints: Number of participants that experience Adverse Events at Day 71, Number of participants that experience flu-like symptoms at Day 71 and 5 more. Started Mar 2008; status: completed.
02
Drugs
interferon beta
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02125578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125578.